Viewing Study NCT00622193


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2025-12-25 @ 11:19 PM
Study NCT ID: NCT00622193
Status: COMPLETED
Last Update Posted: 2017-04-14
First Post: 2008-02-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
Sponsor: Helsinn Therapeutics (U.S.), Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module